Search research articles
Contact Us
Filters
Showing results (81-90 of 165) with videos related to
Page
of 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2023
Improved Posttransplant Outcomes in Recent Years for AML Patients with FLT3-ITD and Wild-type NPM1: A Report from the EBMT Acute Leukemia Working Party
Ali Bazarbachi, Myriam Labopin, Tobias Gedde-Dahl, et al.
Blood
|
March 6, 2012
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes
Felicitas Thol, Sofia Kade, Carola Schlarmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2020
Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years
Ali Bazarbachi, Christoph Schmid, Myriam Labopin, et al.
Blood
|
March 23, 2006
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid, Michael Schleuning, Rainer Schwerdtfeger, et al.
Bone Marrow Transplantation
|
May 29, 2025
Prognostic significance of cytogenetic risk score in patients with secondary acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-matched unrelated donors: a study from the ALWP /EBMT
Arnon Nagler, Allain-Thibeault Ferhat, Sarah Kayser, et al.
Oncology Research and Treatment
|
January 10, 2024
Management of Patients Undergoing CAR-T Cell Therapy in Germany
Olaf Penack, Peter Dreger, Salem Ajib, et al.
American Journal of Hematology
|
November 18, 2024
The role of allogeneic stem cell transplantation in acute myeloid leukemia with translocation t(8;16)(p11;p13)
Ann-Kristin Schmälter, Myriam Labopin, Jurjen Versluis, et al.
The Journal of Infection
|
July 3, 2024
Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: A multi-centre observational study
Sina M Hopff, Sebastian M Wingen-Heimann, Annika Y Classen, et al.
Transplantation and Cellular Therapy
|
July 28, 2024
Impact of the Type of Tyrosine Kinase Inhibitor (imatinib or dasatinib) Used Before allo-HCT on Outcome of Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia. A Study on Behalf of the Acute Leukemia Working Party of the EBMT
Sebastian Giebel, Myriam Labopin, Zinaida Peric, et al.
Bone Marrow Transplantation
|
December 6, 2025
Reduced intensity conditioning with 8 Gy total body irradiation in adult patients with acute lymphoblastic leukemia
Klaus Wethmar, Matthias Edinger, Kerstin Schäfer-Eckart, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 165) with videos related to
Sort By:
Page
of 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2023
Improved Posttransplant Outcomes in Recent Years for AML Patients with FLT3-ITD and Wild-type NPM1: A Report from the EBMT Acute Leukemia Working Party
Ali Bazarbachi, Myriam Labopin, Tobias Gedde-Dahl, et al.
Blood
|
March 6, 2012
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes
Felicitas Thol, Sofia Kade, Carola Schlarmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2020
Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years
Ali Bazarbachi, Christoph Schmid, Myriam Labopin, et al.
Blood
|
March 23, 2006
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid, Michael Schleuning, Rainer Schwerdtfeger, et al.
Bone Marrow Transplantation
|
May 29, 2025
Prognostic significance of cytogenetic risk score in patients with secondary acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-matched unrelated donors: a study from the ALWP /EBMT
Arnon Nagler, Allain-Thibeault Ferhat, Sarah Kayser, et al.
Oncology Research and Treatment
|
January 10, 2024
Management of Patients Undergoing CAR-T Cell Therapy in Germany
Olaf Penack, Peter Dreger, Salem Ajib, et al.
American Journal of Hematology
|
November 18, 2024
The role of allogeneic stem cell transplantation in acute myeloid leukemia with translocation t(8;16)(p11;p13)
Ann-Kristin Schmälter, Myriam Labopin, Jurjen Versluis, et al.
The Journal of Infection
|
July 3, 2024
Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: A multi-centre observational study
Sina M Hopff, Sebastian M Wingen-Heimann, Annika Y Classen, et al.
Transplantation and Cellular Therapy
|
July 28, 2024
Impact of the Type of Tyrosine Kinase Inhibitor (imatinib or dasatinib) Used Before allo-HCT on Outcome of Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia. A Study on Behalf of the Acute Leukemia Working Party of the EBMT
Sebastian Giebel, Myriam Labopin, Zinaida Peric, et al.
Bone Marrow Transplantation
|
December 6, 2025
Reduced intensity conditioning with 8 Gy total body irradiation in adult patients with acute lymphoblastic leukemia
Klaus Wethmar, Matthias Edinger, Kerstin Schäfer-Eckart, et al.
Page
of 17